Publicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (9)

2023

  1. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes

    Clinical Kidney Journal, Vol. 16, Núm. 10, pp. 1656-1663

2021

  1. Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: The RENALCRYOGLOBULINEMIC study

    Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 586-592

  2. Impact of Serum Magnesium Levels on Kidney and Cardiovascular Prognosis and Mortality in CKD Patients

    Journal of Renal Nutrition, Vol. 31, Núm. 5, pp. 494-502

  3. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Kidney International, Vol. 99, Núm. 4, pp. 986-998

2020

  1. Risk factors for non-diabetic renal disease in diabetic patients

    Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388

2018

  1. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)

    Cardiovascular Drugs and Therapy, Vol. 32, Núm. 3, pp. 255-263

2017

  1. Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 125, pp. 8-13

2015

  1. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 3, pp. 467-474

2006

  1. Dual blockade of the renin-angiotensin system in the progression of renal disease: The need for more clinical trials

    Journal of the American Society of Nephrology